Results 251 to 260 of about 148,658 (326)

Application of Metagenomic Long-Read Sequencing for the Diagnosis of Herpetic Uveitis. [PDF]

open access: yesInvest Ophthalmol Vis Sci
Koyanagi Y   +16 more
europepmc   +1 more source

Candida Endophthalmitis Presenting as Bilateral Posterior Uveitis [PDF]

open access: bronze, 1983
Sarah Vicker   +2 more
openalex   +1 more source

M6A Modified miR‐31‐5p Suppresses M1 Macrophage Polarization and Autoimmune Dry Eye by Targeting P2RX7

open access: yesAdvanced Science, Volume 12, Issue 17, May 8, 2025.
The upregulation of FTO in autoimmune dry eye suppresses the recognition of pri‐miR‐31 by DGCR8, thereby inhibiting the maturation of miR‐31‐5p and reducing its inhibitory effect on the target gene P2RX7. The activation of P2RX7 subsequently triggers the p38 MAPK signaling pathway and increases the level of M1‐related genes, thus exacerbating the ...
Lu Zhao   +10 more
wiley   +1 more source

An unusual uveitis in Tanzanian children. [PDF]

open access: bronze, 1989
David Yorston   +2 more
openalex   +1 more source

Ophthalmological manifestations and plasma markers of inflammation in Ebola survivors in post-treatment era. [PDF]

open access: yesSci Rep
Mwanza JC   +16 more
europepmc   +1 more source

Updates on Toll‐Like Receptor 10 Research

open access: yesEuropean Journal of Immunology, Volume 55, Issue 5, May 2025.
Toll‐like receptor 10 (TLR10 or CD290) shares the same structural organization as the other TLRs but shows a unique expression pattern and distinct functional activities yet to be fully elucidated. This review summarizes key steps and recent updates on TLR10 research including open questions and future perspectives.
Federica Riva, Marta Muzio
wiley   +1 more source

Quantitative levels of interferon gamma as a biomarker in the aqueous and serum samples of infectious and noninfectious uveitis patients. [PDF]

open access: yesJ Ophthalmic Inflamm Infect
Shaban SSEM   +12 more
europepmc   +1 more source

Clinical Progress in Mesenchymal Stem Cell Therapy: A Focus on Rheumatic Diseases

open access: yesImmunity, Inflammation and Disease, Volume 13, Issue 5, May 2025.
ABSTRACT Background Rheumatic diseases are chronic immune‐mediated disorders affecting multiple organ systems and significantly impairing patients' quality of life. Current treatments primarily provide symptomatic relief without offering a cure. Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic option due to their ability to ...
Helal F. Hetta   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy